 progress report stroke prevent atrial fibril studi stroke prevent atrial fibril studi spaf investig engl med benefici effect warfarin aspirin placebo primari prevent ischem stroke system embol patient nonvalvular atrial fibril warfarin-elig patient event rate /yr activ antithrombot therapi warfarin aspirin /yr placebo risk reduct confid interv benefici effect aspirin warfarin-inelig patient basi result studi antithrombot agent insight appar aspirin unrespons patient interpret preliminari result reshap studi complex continu blind investig certain portion data present account studi incept recent redesign